We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MSEX:NASDAQMiddlesex Water Company Analysis

Data as of 2026-08-01 - not real-time

$57.30

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Middlesex Water’s stock is trading comfortably above its short‑term and medium‑term moving averages, reinforcing a bullish price trend despite a bearish MACD crossover that hints at short‑term pressure. Momentum indicators sit in a neutral zone, while trading volume has been tapering, suggesting reduced buying enthusiasm. The price is perched near a key resistance level and well above the recent support floor, with volatility that is elevated for a utility but still moderated by a slightly negative beta, underscoring its defensive character. The market sentiment index is in the extreme greed territory, reflecting strong investor optimism.
Fundamentally, the company delivers solid revenue growth and healthy operating margins, supporting a dividend yield that remains attractive for income seekers. The payout ratio is moderate, and operating cash flow is robust, though free cash flow is currently negative and debt levels are notable for a regulated business. A discounted cash flow model places intrinsic value below the current price, indicating limited upside. Recent news confirms a fresh dividend declaration and ongoing infrastructure investment, which bolster the long‑term stability narrative.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • price near resistance with bearish MACD signal
  • declining volume indicating waning buying pressure
  • valuation above intrinsic estimates

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • stable regulated revenue stream
  • moderate dividend yield with sustainable payout
  • industry defensive characteristics offsetting volatility

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • consistent dividend payments and attractive yield
  • strong operating margins and cash flow generation
  • long‑term infrastructure investments supporting growth

Key Metrics & Analysis

Financial Health

Revenue Growth14.30%
Profit Margin23.26%
P/E Ratio22.1
ROE9.77%
ROA2.96%
Debt/Equity83.98
P/B Ratio2.1
Op. Cash Flow$58.6M
Free Cash Flow$-28346000
Industry P/E20.5

Technical Analysis

TrendBullish
RSI57.6
Support$53.08
Resistance$59.00
MA 20$56.15
MA 50$54.39
MA 200$53.29
MACDBearish
VolumeDecreasing
Fear & Greed Index92.88

Valuation

Fair Value$27.38
Target Price$60.00
Upside/Downside4.71%
GradeOvervalued
TypeValue
Dividend Yield2.51%

Risk Assessment

Beta-0.14
Volatility24.54%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.